Home

Terrie Curran

CIK 1690298 · President and Chief Executive · last filed 2026-08-28

Terrie Curran is a President and Chief Executive who has filed 60 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for ARQT, was dated Aug 28, 2026. Across all open-market trades the lifetime net is −$4.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.3M across reported positions. 18 SEC filings were submitted jointly with CELGENE CORP /DE/.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.28M

Companies

4

Total Filings

60

Lifetime Open-Market Net

-$4.78M

Filer Profile

Reported Address
C/O MYOVANT SCIENCES INC.
320 WEST 37TH STREET, 5TH FLOOR
NEW YORK, NY 10018
Related Filers
CELGENE CORP /DE/ — 18 joint filings, latest 2019-11-22
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARQT Director 23,526 $26.89 $632.6K -$1.08M 10 2026-08-28
PHAT President and Chief Executive 364,305 $7.27 $2.65M -$996.6K 19 2025-03-03
Myovant Sciences Ltd. (MYOV) Delisted Director 0 $26.98 $0 -$1.34M 11 2023-03-10
CELGENE CORP /DE/ (CELGZ) Delisted PRES., GLBL INFLAM. AND IMMUN. 19,341 — — -$1.36M 17 2019-11-22

Recent Filings

60 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-28 ARQT Mixed — -$638.9K EDGAR
2026-08-27 ARQT Notice (144) −38,200 -$956.1K EDGAR
2026-08-24 ARQT Mixed — -$19.9K EDGAR
2026-08-20 ARQT Notice (144) −1,072 -$27.9K EDGAR
2026-06-09 ARQT Grant (A) +5,778 $0 EDGAR
2025-06-16 ARQT Grant (A) +7,609 $0 EDGAR
2025-03-03 PHAT Grant (A) — $0 EDGAR
2025-01-23 PHAT Sell (S) −19,109 -$125.9K EDGAR
2024-11-13 ARQT Sell (S) −8,687 -$94.2K EDGAR
2024-11-12 ARQT Notice (144) −8,687 -$94.2K EDGAR
Showing 1–10 of 60
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.